May 21, 2021 /

Webinar: ASP0367 Development Program Update (May 19, 2021)

by: Parent Project Muscular Dystrophy

Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program.

Research & Clinical Trial Webinars,

4 years ago

You may also like

Advocating for Access: Navigating Approved Therapies in Duchenne

Advocating for Access: Navigating Approved Therapies in Duchenne

2 years ago

Webinar: ELEVIDYS Approval: What this means for you and your family

Webinar: ELEVIDYS Approval: What this means for you and your family

2 years ago

Webinar: ENVISION Study Update with Sarepta Therapeutics

Webinar: ENVISION Study Update with Sarepta Therapeutics

2 years ago

Research & Clinical Trial Webinars,

Community Town Hall: SRP-9001 Advisory Committee Update (May 2023)

Community Town Hall: SRP-9001 Advisory Committee Update (May 2023)

2 years ago

Research & Clinical Trial Webinars,

Webinar: Edgewise — A Novel Approach Designed to Protect Muscle in Becker (May 2023)

Webinar: Edgewise — A Novel Approach Designed to Protect Muscle in Becker (May 2023)

2 years ago

Research & Clinical Trial Webinars,

Webinar: Dyne Therapeutics — Advancing FORCE in the Pursuit of Therapies (April 2023)

Webinar: Dyne Therapeutics — Advancing FORCE in the Pursuit of Therapies (April 2023)

2 years ago

Research & Clinical Trial Webinars,

Connect With the Experts: Bone Health in Duchenne (April 2023)

Connect With the Experts: Bone Health in Duchenne (April 2023)

2 years ago

Webinar: Viltepso, An FDA-Approved Treatment for Patients Amenable to Exon 53 Skipping (March 2023)

Webinar: Viltepso, An FDA-Approved Treatment for Patients Amenable to Exon 53 Skipping (March 2023)

2 years ago

Research & Clinical Trial Webinars,

«1…4 567 8…27 »

Page 6 of 27

Join Our Mailing List